Monozyme India Limited
About Monozyme India Limited
Data last updated:
Monozyme India Limited is a public limited company based in Secunderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 July 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN L24239TG1989PLC010220. The company has 1 GST registration on record, which is no longer active. It is recorded as listed by MCA, but its shares were delisted from BSE · penal reasons, and no longer trade on a stock exchange.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.12 Cr. It was formerly known as Monozyme India Private Limited. It is led by directors including Anand Maloo and Kali Chand Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Secunderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹16,600, a growth of 14% compared to the previous year. For the same year it recorded a net loss of ₹34,600 (net margin -208.4%) and EBITDA of ₹2,400 (EBITDA margin 14.5%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
As per MCA filings, the company has open charges of ₹7.59 Cr and satisfied charges of ₹12.21 Cr on record. Court records list 11 cases involving the company, including 8 filed by the company and 3 filed against it; 2 cases are pending. The company has 25 deals on record (25 market trades); the latest was in May 2008. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Bonafide Nutrition Private Limited with revenue of ₹18,132.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Monozyme India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24239TG1989PLC010220, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24239TG1989PLC010220 | Current |
| L24239AP1989PLC010220 | Previous |
| L24239AP1989PTC010220 | Previous |
Contact details
Monozyme India Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFirst Floor H.No.1 – 5 – 1002/3 Sri Sai Krupa Sri Nagar Colony Bhoopathi Rao Nagar O, Ld Alwal, Secunderabad, Telangana, India – 500010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Monozyme India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Monozyme India Limited
FY 2025 filings availableMonozyme India Limited reported revenue of ₹16,600 (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 14% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹16,600 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,400 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹34,600 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.5% | ||||
| Net Profit Margin | -208.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Monozyme India Limited, buy the company report.
Board of directors of Monozyme India Limited
Monozyme India has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Maloo Also directs: Maloo Brothers LLP | Director | 30 Oct 2004 | 21 Years 11 Months | Current |
| Kali Chand Sharma | Director | 16 Feb 2008 | 18 Years 8 Months | Current |
| Veeram Venugopal Reddy | Director | 28 Feb 2005 | 21 Years 7 Months | Current |
| Rabindra Kumar Walia | Director | 16 Feb 2008 | 18 Years 8 Months | Current |
| Bijinder Nath Rattan | Director | 01 Feb 2007 | 19 Years 8 Months | Current |
Peer comparison
Monozyme India Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bonafide Nutrition Private Limited | ₹18,132 (FY 2024) | -98.0% | Yamuna Nagar, Haryana, India | |||
| V3 Biotechnologies Private Limited | ₹17,500 (FY 2025) | 8.0% | Kolkata, West Bengal, India | |||
| D I Laboratories Ltd | ₹17,240 (FY 2024) | -97.0% | Kolkata, West Bengal, India | |||
| DMK Ventures Private Limited | ₹17,000 (FY 2025) | -70.0% | Ahmedabad, Gujarat, India | |||
| GSR International Private Limited | ₹16,855 (FY 2017) | 77.0% | New Delhi, Delhi, India | |||
| Monozyme India Limitedthis company | ₹16,600 (FY 2025) | -₹34,600 | -208.4% | 14.0% | Secunderabad, Telangana, India | |
| Sanjhi Foodco Industries Private Limited | ₹16,437 (FY 2025) | 0.0% | Nagpur, Maharashtra, India | |||
| Shakti Bio Science Limited | ₹16,378 (FY 2025) | -99.0% | Vapi, Gujarat, India | |||
| Icon Lifesciences Private Limited | ₹16,311 (FY 2015) | -7.0% | Mumbai, Maharashtra, India | |||
| Kamlalay Health Care Private Limited | ₹16,210 (FY 2024) | -97.0% | Buxar, Bihar, India | |||
| Malwin Pharma Private Limited | ₹16,206 (FY 2024) | -90.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Monozyme India Limited, buy the company report.
Auditor
Monozyme India Limited is audited by Srivastava & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Srivastava & Associates | FY 2023 | 328467E |
Shareholding
The shareholding of Monozyme India Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Monozyme India Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Sep 2005 | 90123343 | Oriental Bank Commarce | ₹7.15 Cr | Open | |
| 29 Mar 1990 | 90120377 | Technology Developmen and Inforanationcompanyof India Limite | ₹44 Lakh | Open | |
| 07 Mar 2001 | 90122952 | State Bank of Hyderabad | ₹2 Cr | Satisfied | |
| 07 Mar 2001 | 90124233 | State Bank of Hyderabad | ₹2 Cr | Satisfied | |
| 03 Jun 1996 | 90123860 | State Bank of Hyderabad | ₹81 Lakh | Satisfied |
To see the full charge records of Monozyme India Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Monozyme India Limited has 25 deals on record (25 market trades); the latest was in May 2008.
Deals on record (5 of 25)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2008 | Market trade | ₹2.5 Lakh | Buyer: an individual |
| Dec 2007 | Market trade | ₹5.6 Lakh | Seller: Upturn Securities Private Limited |
| Dec 2007 | Market trade | ₹3.4 Lakh | Seller: Upturn Securities Private Limited |
| Nov 2007 | Market trade | ₹1.6 Lakh | Seller: Upturn Securities Private Limited |
| Mar 2006 | Market trade | ₹7.3 Lakh | Buyer: Abhyudya Trading Ltd Seller: Exim Scrips Dealers Pvt L |
To see the full deal history of Monozyme India Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Monozyme India Limited has 11 court cases on record: 8 filed by Monozyme India, 3 filed against it. 2 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 2 | 2 |
| District courts | 4 | 1 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Company petition | Filed against the company by Reliance Infocomm Ltd., and 1 other | Disposed |
| High Court, West Bengal | Court case (CRR) | Filed by the company against State of West Bengal and Anr | Pending |
| Calcutta High Court | Court case (CRR) | Filed by the company against an individual | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against an individual | Disposed |
| District court, Calcutta, West Bengal | Revision petition | Filed by the company against State of West Bengal | Disposed |
To see the full case history of Monozyme India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Monozyme India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Monozyme India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Monozyme India Limited, buy the company report.
Recent activity
Monozyme India Limited has 6 board changes on record since 2004: 5 appointments and 1 cessation. The latest: Aditya Sarda ceased to be Managing Director on 13 Mar 2008.
20 earlier events are in the company report.
Frequently asked questions
Monozyme India is an active public limited company based in Secunderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 July 1989 (37+ years old) and is registered under CIN L24239TG1989PLC010220.
Monozyme India has 5 current directors:
- Anand Maloo - Director
- Kali Chand Sharma - Director
- Veeram Venugopal Reddy - Director
- Rabindra Kumar Walia - Director
- Bijinder Nath Rattan - Director
The latest financial statements of Monozyme India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Monozyme India has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Monozyme India is L24239TG1989PLC010220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Monozyme India is recorded as a listed company by MCA, but its shares were delisted from BSE · penal reasons, and no longer trade on a stock exchange.
Monozyme India has 11 court cases on record: 8 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.
Monozyme India was incorporated on 07 July 1989, making it 37+ years old. It is registered with the Registrar of Companies, Hyderabad.
Monozyme India has 25 deals on record (25 market trades); the latest was in May 2008.
The peers of Monozyme India by revenue are Bonafide Nutrition Private Limited, V3 Biotechnologies Private Limited, D I Laboratories Ltd, DMK Ventures Private Limited, GSR International Private Limited and 5 more, all in the Pharma industry (Formulations).
Aditya Sarda ceased to be Managing Director on 13 Mar 2008. Kali Chand Sharma was appointed as Director on 16 Feb 2008. Rabindra Kumar Walia was appointed as Director on 16 Feb 2008. Monozyme India has 6 board changes on record in total.